Immunobiology Unit 6 Review: B Cell Development and Antibody Production

B Cell Basics

• B cells are a type of white blood cell (lymphocyte) that play a crucial role in the adaptive immune system
• Originate from hematopoietic stem cells in the bone marrow and undergo a complex developmental process
• Express unique B cell receptors (BCRs) on their surface, which are membrane-bound antibodies
• BCRs recognize specific antigens and initiate B cell activation and differentiation
• Secrete antibodies, which are soluble forms of the BCR, to neutralize and eliminate pathogens
• Collaborate with T cells and other immune cells to mount an effective immune response
• Can differentiate into plasma cells, which are specialized antibody-producing cells
• Contribute to the formation of immunological memory, providing long-lasting protection against reinfection

B Cell Development Stages

• B cell development occurs in the bone marrow and involves several distinct stages
• Hematopoietic stem cells give rise to common lymphoid progenitors (CLPs), which are the precursors of B cells
• CLPs differentiate into pro-B cells, the earliest stage of B cell development
  • Pro-B cells begin rearranging their immunoglobulin heavy chain genes (VDJ recombination)
• Pro-B cells develop into pre-B cells, which express a pre-B cell receptor (pre-BCR) on their surface
  • Pre-BCR consists of a successfully rearranged heavy chain paired with a surrogate light chain
  • Pre-BCR signaling promotes cell survival and proliferation
• Pre-B cells differentiate into immature B cells, which express a complete BCR (IgM) on their surface
• Immature B cells undergo negative selection to eliminate self-reactive cells and ensure self-tolerance
• Surviving immature B cells migrate to secondary lymphoid organs (spleen, lymph nodes) as mature naive B cells
• Mature naive B cells circulate in the bloodstream and lymphatic system, ready to encounter their specific antigen

Antibody Structure and Function

• Antibodies, also known as immunoglobulins (Ig), are Y-shaped proteins produced by B cells
• Consist of four polypeptide chains: two identical heavy chains and two identical light chains
• Heavy and light chains are connected by disulfide bonds, forming a flexible hinge region
• Each antibody has two antigen-binding sites (Fab regions) at the tips of the Y-shaped structure
  • Fab regions contain variable domains that determine antigen specificity
• The stem of the Y-shaped structure is called the Fc region, which mediates effector functions
  • Fc region interacts with complement proteins and Fc receptors on immune cells
• Antibodies have several functions in the immune response:
  • Neutralization: Binding to pathogens or toxins, preventing their entry into cells
  • Opsonization: Coating pathogens to enhance phagocytosis by macrophages and neutrophils
  • Complement activation: Triggering the complement cascade to promote pathogen elimination
  • Antibody-dependent cell-mediated cytotoxicity (ADCC): Directing natural killer cells to destroy infected or cancerous cells

Antibody Production Process

• Antibody production begins when a naive B cell encounters its specific antigen
• Antigen binds to the BCR on the B cell surface, triggering B cell activation
• Activated B cells migrate to germinal centers in secondary lymphoid organs (spleen, lymph nodes)
• In the germinal centers, B cells undergo clonal expansion, producing many identical copies of themselves
• B cells also undergo somatic hypermutation, introducing random mutations in their immunoglobulin genes
  • Somatic hypermutation generates antibodies with higher affinity for the antigen
• B cells with high-affinity antibodies are positively selected and differentiate into plasma cells or memory B cells
• Plasma cells secrete large quantities of antibodies into the bloodstream and other body fluids
• Memory B cells provide long-lasting protection and can quickly respond to future encounters with the same antigen
• Antibody production is regulated by cytokines and interactions with T helper cells
  • T helper cells provide co-stimulatory signals (CD40L) and cytokines (IL-4, IL-21) to support B cell differentiation

B Cell Activation and Differentiation

• B cell activation occurs when a naive B cell encounters its specific antigen
• Antigen binds to the BCR on the B cell surface, triggering intracellular signaling cascades
• B cells can be activated through two main pathways: T cell-dependent (TD) and T cell-independent (TI)
  • TD activation requires help from T helper cells, which provide co-stimulatory signals and cytokines
  • TI activation occurs in response to certain antigens (polysaccharides, lipids) that can directly stimulate B cells
• Activated B cells differentiate into either plasma cells or memory B cells
• Plasma cells are terminally differentiated cells that secrete large quantities of antibodies
  • Plasma cells migrate to the bone marrow and can survive for months or years, providing sustained antibody production
• Memory B cells are long-lived cells that persist after the primary immune response
  • Memory B cells express high-affinity BCRs and can quickly differentiate into plasma cells upon re-exposure to the antigen
• B cell differentiation is regulated by transcription factors (Blimp-1, IRF4) and epigenetic modifications
• Cytokines (IL-4, IL-21) and cell-cell interactions (CD40-CD40L) also influence B cell fate decisions

Types of Antibodies

• There are five main classes (isotypes) of antibodies: IgM, IgD, IgG, IgA, and IgE
• Each isotype has distinct structural and functional properties, adapted for specific roles in the immune response
• IgM: The first antibody produced during a primary immune response
  • Exists as a pentamer, with ten antigen-binding sites
  • Efficient at activating complement and agglutinating pathogens
• IgD: Expressed on the surface of mature naive B cells, alongside IgM
  • Function is not fully understood, but may regulate B cell activation and survival
• IgG: The most abundant antibody in serum and extracellular fluid
  • Exists as a monomer, with two antigen-binding sites
  • Plays a key role in neutralization, opsonization, and ADCC
  • Can cross the placenta, providing passive immunity to the fetus
• IgA: The main antibody in secretions (mucus, saliva, tears, breast milk)
  • Exists as a dimer, joined by a secretory component
  • Protects mucosal surfaces from pathogens and maintains microbiome homeostasis
• IgE: Involved in allergic reactions and defense against parasites
  • Binds to Fc receptors on mast cells and basophils, triggering the release of inflammatory mediators

B Cell Memory and Long-Term Immunity

• B cell memory is a key feature of the adaptive immune system, providing long-lasting protection against reinfection
• Memory B cells are generated during the primary immune response and persist for years or decades
• Memory B cells express high-affinity BCRs and can quickly differentiate into plasma cells upon re-exposure to the antigen
• Memory B cells are maintained in a quiescent state in the bone marrow and secondary lymphoid organs
  • Survival and maintenance of memory B cells depend on cytokines (IL-7, BAFF) and interactions with stromal cells
• Memory B cells can be reactivated by antigen or by non-specific stimuli (toll-like receptor ligands, cytokines)
• Reactivated memory B cells undergo rapid clonal expansion and differentiation, generating a robust secondary immune response
  • Secondary immune response is faster, stronger, and more specific than the primary response
• B cell memory is the basis for long-term immunity induced by vaccination
  • Vaccines stimulate the production of memory B cells and long-lived plasma cells, providing protection against infectious diseases

Clinical Relevance and Applications

• B cell disorders can lead to immunodeficiencies, autoimmunity, and malignancies
• X-linked agammaglobulinemia (XLA) is a genetic disorder characterized by the absence of mature B cells and antibodies
  • Caused by mutations in the BTK gene, which is essential for B cell development
  • Patients with XLA are susceptible to recurrent bacterial infections and require lifelong immunoglobulin replacement therapy
• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies against nuclear antigens
  • B cells play a central role in the pathogenesis of SLE, through antibody production and cytokine secretion
  • Treatment strategies for SLE include B cell depletion (rituximab) and inhibition of B cell survival factors (belimumab)
• Multiple myeloma is a malignancy of plasma cells, characterized by the accumulation of monoclonal antibodies in the blood and urine
  • Caused by genetic and epigenetic alterations in plasma cells, leading to uncontrolled proliferation and survival
  • Treatment options include chemotherapy, proteasome inhibitors (bortezomib), and immunomodulatory drugs (lenalidomide)
• Monoclonal antibodies are widely used as therapeutic agents for cancer, autoimmunity, and infectious diseases
  • Produced by immortalized B cell clones (hybridomas) or by recombinant DNA technology
  • Examples include rituximab (anti-CD20) for B cell lymphomas, adalimumab (anti-TNF) for rheumatoid arthritis, and palivizumab (anti-RSV) for respiratory syncytial virus infection